ONENATAL Trademark

Trademark Overview


On Monday, September 1, 2025, a trademark application was filed for ONENATAL with the United States Patent and Trademark Office. The USPTO has given the ONENATAL trademark a serial number of 99367890. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, February 2, 2026. This trademark is owned by AKRON PHARMA INC.. The ONENATAL trademark is filed in the Pharmaceutical Products category with the following description:

Hemorrhoid preparations; Antiseptic wipes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, HIV, malaria,; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Transdermal patches for use in the treatment of lumbago; Poultices; Pharmaceutical preparations for treating diabetes; Sticking plasters for medical use; Medical diagnostic test strips for use in the field of pregnancy testing; Disposable liners for diapers; Medical adhesive tape; Pregnancy testing preparations; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies, gels; Smoking cessation preparations
onenatal

General Information


Serial Number99367890
Word MarkONENATAL
Filing DateMonday, September 1, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, February 2, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, February 24, 2026

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Description of MarkThe mark consists of the stylized wording "ONENATAL".
Goods and ServicesHemorrhoid preparations; Antiseptic wipes; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, HIV, malaria,; Medicinal preparations for the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Transdermal patches for use in the treatment of lumbago; Poultices; Pharmaceutical preparations for treating diabetes; Sticking plasters for medical use; Medical diagnostic test strips for use in the field of pregnancy testing; Disposable liners for diapers; Medical adhesive tape; Pregnancy testing preparations; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies, gels; Smoking cessation preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, September 1, 2025
Primary Code005
First Use Anywhere DateFriday, July 11, 2025
First Use In Commerce DateFriday, July 11, 2025

Trademark Owner History


Party NameAKRON PHARMA INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 11725

Trademark Events


Event DateEvent Description
Monday, September 1, 2025NEW APPLICATION ENTERED
Monday, September 1, 2025APPLICATION FILING RECEIPT MAILED
Wednesday, January 21, 2026NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, January 22, 2026ASSIGNED TO EXAMINER
Tuesday, January 27, 2026EXAMINERS AMENDMENT -WRITTEN
Tuesday, January 27, 2026EXAMINERS AMENDMENT E-MAILED
Tuesday, January 27, 2026NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, January 27, 2026EXAMINER'S AMENDMENT ENTERED
Tuesday, January 27, 2026APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 18, 2026NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED